Related Experiment Videos
[Treatment of hemophilia in children]
C Stucchi1, A Giovanniello, M Dozzi
1Clinica Pediatrica I dell'Università di Milano, Italia.
Insights
Pediatric hemophilia management has advanced, focusing on preventing viral infections like HIV and hepatitis through improved blood products. Comprehensive care, including psychosocial support, is crucial for improving the quality of life for children with hemophilia.
Area of Science:
- Pediatric Hematology
- Transfusion Medicine
- Infectious Disease Prevention
Background:
- Hemophilia is increasingly recognized as a pediatric condition due to advances in prenatal diagnosis and early detection.
- Childhood hemophilia treatment has evolved significantly, impacting patient quality of life.
- Two major therapeutic shifts have occurred: improved blood product safety and comprehensive patient support.
Purpose of the Study:
- To review advancements in pediatric hemophilia care.
- To discuss strategies for preventing viral infections (HIV, hepatitis) in hemophiliacs.
- To emphasize the importance of integrated, pediatric-focused care models.
Main Methods:
- Review of current practices in hemophilia treatment.
- Analysis of viral transmission prevention in blood products (donor screening, heat treatment).
- Examination of global assistance models including acute bleed management and psychosocial support.
Main Results:
- Enhanced safety of blood products has reduced viral transmission rates (HIV, hepatitis).
- Integrated care models combining medical and psychosocial support improve outcomes.
- Specialized pediatric environments are optimal for managing hemophilic children.
Conclusions:
- Modern hemophilia care requires a multidisciplinary approach centered on the pediatric patient.
- Continued vigilance in blood product safety and robust psychosocial support are essential.
- Specialized pediatric care centers provide the best environment for managing hemophilia.
Abstract:
Thanks to recent developments and evolution in prenatal diagnosis and early onset within the first year of life, hemophilia may now be considered a pathology of primarily pediatric interest. The treatment of hemophilia in children has furthermore undergone a number of changes that include 2 main events in therapy that have served to modify the quality of life of the hemophiliac. The first of these events regards blood products and the prevention of viral infections, hepatitis and HIV transmission. Prevention is based on various factors which include: donor selection, immunization, product testing and heat treatment of blood products. The second extremely important aspect of treatment in hemophilia is the concept of global assistance, which includes: the treatment of the bleeding episode itself, and an ongoing psycho-social support system. In this paper we suggest some practical treatment schedules for the therapy of bleeding episodes in addition to examining the severe side effects of HIV and Hepatitis viruses. The message which our paper attempts to transmit is that the hemophilic child must be ideally assisted in an exclusively pediatric environment.